Latest Half Year Financial Results News

Australian Ethical reported a slight 1% decline in funds under management to $14.08 billion for December 2025, balancing positive retail flows against institutional mandate losses and market headwinds.

The Lottery Corporation will release its half year financial results for the period ending 31 December 2025 on 18 February 2026, alongside key dates for its interim dividend.

IAG has integrated RACQ Insurance into its core reinsurance programs, expanding catastrophe coverage and boosting downside protection through to 2029. This move aims to stabilise earnings and unlock synergies following RACQ’s acquisition.

Stockland has announced an estimated 9.0 cents per security distribution for the first half of FY26, alongside a 1% discount on reinvested dividends through its Distribution Reinvestment Plan.

Tamawood Limited anticipates a substantial 40% to 50% increase in first-half FY26 profit before tax, driven by a 36.5% rise in sales and improved Work In Progress reporting confirmed by auditors.

Revolution Private Credit Income Trust has reported a solid $3.4 million operating profit for its inaugural half-year period, delivering a net return of 0.93% since listing and outperforming its benchmark. The Trust also declared a distribution of 0.35 cents per unit for October 2025.

CTI Logistics Limited anticipates a significant 55% increase in profit before tax for the half year ending December 2025, driven by robust revenue growth and operational improvements in Western Australia.

APA Group has announced a modest 1.9% increase in its interim distribution to 27.5 cents per security for the half year ending December 2025, maintaining steady income growth for investors.

Charter Hall Limited has announced a 6% increase in its half-year distribution to 24.83 cents per security for the period ending December 31, 2025, reflecting steady growth in its property investment portfolio.

Metcash Limited reported a marginal rise in sales revenue to $8.48 billion for 1H26, with underlying EBITDA up 2% driven by Food pillar growth, while EBIT declined 2.4% amid challenges in Liquor and Hardware segments. The Board declared an interim fully franked dividend of 8.5 cents per share.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Web Travel Group Limited reports robust half-year results for FY26, with its B2B travel division WebBeds fueling a 20% revenue increase despite rising costs and finance pressures.